Form 10-Q XOMA Corp For: Jun 30

Related Keywords

United States ,California ,San Francisco Bay ,Delaware ,Ukraine ,Emeryville ,Washington ,American ,America ,Rowen Hughes ,Chiesi Farmaceutici ,Jamesr Neal ,Biosasis Rpas ,Incyte Europe ,Monte Carlo ,Thomas Burns ,Bradley Sitko ,Denovo Biopharma ,Servier ,Corporation Law ,Merck Kga ,Agenus Inc ,Public Health Service ,Human Services ,Cytrx Corporation ,Investment Company ,European Commission ,Company Collaboration Agreement ,Novartis Institutes For Biomedical Research Inc ,Health Insurance Portability ,Nanotherapeutics Inc ,Immunitybio Inc ,Hc Wainwright Co ,Affitech Research ,Prothena Biosciences ,Silicon Valley Bank ,Molecular Templates Inc ,Deposit Insurance Corporation ,Service Period ,Signature Bank ,Diagnostics Inc ,Organon International Gmb ,California Department Of Financial Protection ,Exchange Commission ,Company Royalty Purchase Agreement ,Oncobiologics Inc ,Takeda Pharmaceutical Company ,Ology Bioservices Inc ,Merck Sharp Dohme Corp ,Janssen Biotech Inc ,Company Commercial Payment Purchase Agreement ,Securities Exchange ,Company Seriesa Preferred Stock ,Medexus Pharmaceuticals Inc ,Bioasis Technologies Inc ,Chiron Corporation ,European Medicines Agency ,Trademark Office ,Zevra Therapeutics Inc ,Pfizer ,National Institutes Of Health ,Company Series ,Company Board Of Directors ,Company To Aronora ,European Union ,Nantcell Inc ,Dyax Corp ,Commission File No ,Kuros Royalty Fund ,Novartis ,Pfizer Inc ,Centers For Medicare Medicaid Services ,Health Information Technology ,Rezolute Inc ,International Conference On Harmonization Good Clinical Practices ,Wyeth Pharmaceuticals ,Us Supreme Court ,Drug Administration ,Department Of Health ,Regeneron Pharmaceuticals Inc ,Company Ip Acquisition Agreement ,Company Annual Report On Form ,Checkmate Pharmaceuticals ,National Resilience Inc ,Antria Bio Inc ,Company Payment Interest Purchase Agreement ,Ladrx Corporation ,Novartis International Pharmaceutical Ltd ,Health Care ,Merck Kgaa ,B Riley Securities Inc ,Sonnet Biotherapeutics Inc ,Aronora Inc ,Clinical Health ,Biotechnology Value Fund ,Silvergate Capital Corp ,Viracta Therapeutics Inc ,Astrazeneca ,Company Assignment ,Aptevo Therapeutics Inc ,Company License Agreement ,Zip Code ,Cumulative Perpetual Preferred Stock ,Seriesb Cumulative Perpetual Preferred Stock ,Securities Exchange Act ,Interactive Data File ,Regulations T ,Exchange Act ,Term Incentive ,Stock Award Plan ,Market Issuance Sales Agreement ,Company Act ,Patient Protection ,Affordable Care Act ,Education Reconciliation Act ,Commercial Payment Purchase Agreement ,Royalty Purchase Agreement ,Antibody License ,License Agreement ,Letter Agreement ,Officer Employment Agreement ,Payment Interest Purchase Agreement ,Commercial Payment Purchase ,Financial Instruments ,Riley Securities ,Value Fund ,Consumer Privacy Act ,Good Manufacturing ,Collaboration Agreement ,Stock Purchase Plan ,Corrupt Practices Act ,Accountability Act ,Assumption Agreement ,Novartis Institutes ,Biomedical Research ,Novartis Vaccines ,National Resilience ,Severance Plan ,Antria Bio ,Seriesb Preferred ,Preferred Stock ,Seriesb Preferred Stock ,Oxley Act ,Kempharm Denmark ,Purchase Agreement ,Orphazyme Aps ,Annual Report ,Months Ended June ,Cash Flow Information ,Significant Accounting ,Future Revenue ,Black Scholes Model ,United States Treasury ,Future Milestones ,Current Expected Credit ,Share Attributable ,Financial Instruments Credit Losses ,Business Combinations ,Contract Assets ,Contact Liabilities ,Consolidated Financial Statements ,Loss Per Share Attributable ,Common Stockholders ,American Arbitration ,International Centre ,Dispute Resolution ,Organon License Agreement ,Organon License ,Antibody License Agreement ,Gevokizumab License Agreement ,Les Laboratories Servier ,Gevokizumab License ,Exclusivity Option ,Servier Loan ,Takeda Collaboration Agreement ,Molecular Templates ,Takeda Collaboration ,Rezolute License ,Royalty Sale Agreement ,Restated License Agreement ,Royalty Sale Agreements ,Acquisition Agreements ,Ladrx Agreements ,Bioasis Contingent Consideration ,Second Bioasis ,Bayer Product ,Security Agreement ,Bayer Products ,Royalty Milestones ,Aronora Contingent Consideration ,Palo Licensed Products ,Day One Biopharmaceuticals ,Checkmate Pharmaceutical ,Payment Purchase Agreement ,Nasdaq Stock Market ,Aronora Royalty Milestones ,Kuros Sales Milestones ,Affitech Sales Milestones ,Obseva Sales Milestones ,Obseva Non Sales Milestones ,Aptevo Contingent ,Aptevo Contingent Consideration ,Based Compensation ,Stock Options ,Executive Chairman ,Chief Investment Officer ,Option Inducement ,Stock Option Inducement Awards ,Nasdaq Listing Rule ,Amended Retention Plan ,Initial Period ,Restated Employment Agreement ,Departure Date ,Continuity Incentive ,Seriesb Depositary ,Securities Act ,Seriesb Depositary Shares ,President Biden ,Inflation Reduction Act ,Inflation Act ,Quarterly Report ,Private Securities Litigation Reform Act ,Commercial Payment Purchase Agreements ,Collaboration Agreements ,Condensed Consolidated Financial ,Condensed Consolidated Financial Statements ,Milestone Payments ,Interim Chief Executive Officer ,Principal Executive Officer ,Chief Financial Officer ,Investment Company Act ,Royalty Aggregator ,Financial Results ,California Department ,Financial Protection ,Silvergate Capital ,Federal Food ,Cosmetic Act ,International Conference ,Harmonization Good Clinical Practices ,European Clinical Trials Directive ,America Invents Act ,Good Manufacturing Practice ,Data Integrity ,San Francisco Bay Area ,Budget Control Act ,American Taxpayer Relief Act ,American Economy ,Comprehensive Plan ,Addressing High Drug Prices ,Medicaid Innovation ,Medicaid Services ,Anti Kickback Statute ,False Claims Act ,Clinical Health Act ,Trade Control ,Nasdaq Marketplace Rule ,Delaware General Corporation Law ,Revenue Code ,Tax Act ,Interim Chief Executive ,Vice President ,Principal Financial ,Principal Accounting Officer ,